Happlyz Medical reaches a major milestone by obtaining Young Innovative and Disruptive Company (JEIR) status! This status is reserved for companies with strong innovation potential and a significant commitment to research and development. 🚀

As a JEIR, Happlyz Medical will benefit from tax and social security advantages, allowing us to invest even more in our research and development projects, particularly in respiratory data signal processing, a field in which we hold an international patent!
For our investors, this means an attractive 50% tax reduction on the amount invested! This is excellent news as we finalise our Seed round in the coming months. 💰
We are delighted to have reached this new milestone and invite you to contact us quickly about the latest opportunities to invest alongside us! Contact us now to join the Happlyz Medical adventure! 🌟


